PAM
ELDN icon

Panagora Asset Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Panagora Asset Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,628
Closed -$48.2K – 1201
2025
Q3 		$48.2K Buy
+18,628
New +$54.5K ﹤0.01% 1142
2021
Q3 		– Sell
-19
Closed – – 1912
2021
Q2 		$0 Sell
19
-1
-5% -$9 ﹤0.01% 2826
2021
Q1 		$0 Hold
20
– – ﹤0.01% 2846
2020
Q4 		$0 Sell
20
-13
-39% -$248 ﹤0.01% 2835
2020
Q3 		$1K Hold
33
– – ﹤0.01% 2640
2020
Q2 		$0 Hold
33
– – ﹤0.01% 2586
2020
Q1 		$0 Hold
33
– – ﹤0.01% 2537
2019
Q4 		$0 Hold
33
– – ﹤0.01% 2490
2019
Q3 		$0 Sell
33
-191
-85% -$2.75K ﹤0.01% 2509
2019
Q2 		$4K Sell
224
-40
-15% -$1.75K ﹤0.01% 2488
2019
Q1 		$19K Buy
264
+239
+956% +$15.9K ﹤0.01% 2269
2018
Q4 		$1K Sell
25
-548
-96% -$34.9K ﹤0.01% 2420
2018
Q3 		$48K Sell
573
-27
-5% -$2.76K ﹤0.01% 2025
2018
Q2 		$76K Buy
+600
New +$62K ﹤0.01% 1925
2017
Q2 		– Sell
-6
Closed -$1K – 2611
2017
Q1 		$1K Buy
+6
New +$882 ﹤0.01% 2345

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Panagora Asset Management's ELDN Position: Q4 2025 in Review

Panagora Asset Management sold out of Eledon Pharmaceuticals (ELDN) in Q4 2025, closing a stake of 18,628 shares — an estimated $48.2K sold.

Panagora Asset Management first reported a position in ELDN in Q1 2017 and held it in 15 quarters. The position peaked at $76K in Q2 2018. 95 funds tracked by Wall St. Rank hold ELDN as of Q4 2025.

  • Panagora Asset Management reported no remaining Eledon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Panagora Asset Management sold 18,628 Eledon Pharmaceuticals shares in Q4 2025, an estimated $48.2K.
  • Panagora Asset Management first reported a position in Eledon Pharmaceuticals in Q1 2017 and held it in 15 quarters.
  • Panagora Asset Management's Eledon Pharmaceuticals position peaked at $76K in Q2 2018.
  • 95 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q4 2025.

Based on Panagora Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.